Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristoffer Haugarvoll

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Neurology and Neuroscience Reports|July 11, 2006
PARK8 LRRK2 parkinsonismKristoffer Haugarvoll, Zbigniew K Wszolek
Journal of Parkinson'S Disease|August 14, 2013
A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotypeKristoffer Haugarvoll, Laurence A Bindoff
Parkinsonism & Related Disorders|January 20, 2010
Clinical features of LRRK2 parkinsonismKristoffer Haugarvoll, Zbigniew K Wszolek
Annals of Neurology|December 27, 2016
Simvastatin is associated with decreased risk of Parkinson diseaseBrage Brakedal, Kristoffer Haugarvoll, Charalampos Tzoulis
Neurologic Clinics|July 31, 2007
The genetics of frontotemporal dementiaKristoffer Haugarvoll, Zbigniew K Wszolek, Michael Hutton
Neurology|July 23, 2008
Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutationsOwen A Ross, Mathias Toft, Kristoffer Haugarvoll
Brain : a Journal of Neurology|January 27, 2016
Nigrostriatal denervation sine parkinsonismKristoffer Haugarvoll, Laurence A Bindoff, Charalampos Tzoulis
NPJ Parkinson'S Disease|March 3, 2022
A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian populationBrage Brakedal, Lilah Toker, Kristoffer Haugarvoll, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 22, 2015
A woman in her 70s with chronic walking difficultiesIrene H Flønes, Kristoffer Haugarvoll, Christina Sundal, et al.
Plos One|September 7, 2021
NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database studyBrage Brakedal, Charalampos Tzoulis, Ole-Bjørn Tysnes, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Neurology and Neuroscience Reports|July 11, 2006
PARK8 LRRK2 parkinsonismKristoffer Haugarvoll, Zbigniew K Wszolek
Journal of Parkinson'S Disease|August 14, 2013
A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotypeKristoffer Haugarvoll, Laurence A Bindoff
Parkinsonism & Related Disorders|January 20, 2010
Clinical features of LRRK2 parkinsonismKristoffer Haugarvoll, Zbigniew K Wszolek
Annals of Neurology|December 27, 2016
Simvastatin is associated with decreased risk of Parkinson diseaseBrage Brakedal, Kristoffer Haugarvoll, Charalampos Tzoulis
Neurologic Clinics|July 31, 2007
The genetics of frontotemporal dementiaKristoffer Haugarvoll, Zbigniew K Wszolek, Michael Hutton
Neurology|July 23, 2008
Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutationsOwen A Ross, Mathias Toft, Kristoffer Haugarvoll
Brain : a Journal of Neurology|January 27, 2016
Nigrostriatal denervation sine parkinsonismKristoffer Haugarvoll, Laurence A Bindoff, Charalampos Tzoulis
NPJ Parkinson'S Disease|March 3, 2022
A nationwide study of the incidence, prevalence and mortality of Parkinson's disease in the Norwegian populationBrage Brakedal, Lilah Toker, Kristoffer Haugarvoll, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 22, 2015
A woman in her 70s with chronic walking difficultiesIrene H Flønes, Kristoffer Haugarvoll, Christina Sundal, et al.
Plos One|September 7, 2021
NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database studyBrage Brakedal, Charalampos Tzoulis, Ole-Bjørn Tysnes, et al.
Pageof 6